Eidos Therapeutics, Inc

(NASDAQ:EIDX)

Latest On Eidos Therapeutics, Inc (EIDX):

Date/Time Type Description Signal Details
2021-02-12 17:53 ESTNewsAlnylam shares downgraded by Citi amid competitive threatsN/A
2021-01-29 07:37 ESTAnalyst RatingThe Analyst Target Price has increased from $52.75 to $53.63.Neutral
2021-01-28 07:33 ESTAnalyst RatingThe Analyst Target Price has decreased from $71.81 to $52.75.Sell
2021-01-27 07:32 ESTAnalyst RatingThe Analyst Target Price has decreased from $78.71 to $71.81.Sell
2021-01-26 23:11 ESTNewsBridgeBio announces completion of Eidos Therapeutics dealN/A
2021-01-25 07:33 ESTAnalyst RatingThe Analyst Target Price has increased from $70.38 to $78.71.Neutral
2021-01-05 11:42 ESTAnalyst RatingThe Analyst Target Price has increased from $62.83 to $70.38.Neutral
2020-12-14 18:10 ESTNews'Merger Monday' is back as economy continues to recover from COVID-19N/A
2020-11-26 19:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 11:52 ESTAnalyst RatingThe Analyst Target Price has increased from $61.97 to $62.83.Neutral
2020-11-07 15:42 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 16:07 ESTInsider TradeCameron Turtle has directly disposed of 209 shares and currently holds 65,531 shares.Sell
2020-11-03 16:07 ESTInsider TradeCameron Turtle has directly disposed of 3,146 shares and currently holds 65,740 shares.Sell
2020-11-03 16:07 ESTInsider TradeCameron Turtle has directly disposed of 9,145 shares and currently holds 68,886 shares.Sell
2020-11-03 16:07 ESTInsider TradeCameron Turtle has directly acquired 2,500 shares and currently holds 78,031 shares.Buy
2020-11-03 16:07 ESTInsider TradeCameron Turtle has directly acquired 5,000 shares and currently holds 75,531 shares.Buy
2020-11-02 07:38 ESTFinancialsCompany financials have been released.Neutral
2020-10-31 14:49 ESTNewsEidos Therapeutics EPS misses by $0.12N/A
2020-10-30 20:44 ESTEarnings EstimateAn EPS average of -$0.76 is estimated for the quarter ending on March 31, 2021.Buy
2020-10-30 20:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $62.81 to $61.97.Sell
2020-10-30 17:06 ESTInsider TradeUma Sinha has directly disposed of 3,700 shares and currently holds 321,525 shares.Sell
2020-10-30 17:06 ESTInsider TradeUma Sinha has directly disposed of 1,300 shares and currently holds 325,225 shares.Sell
2020-10-09 17:35 ESTInsider TradeFranco Valle has directly disposed of 5,199 shares and currently holds 0 shares.Sell
2020-10-09 17:35 ESTInsider TradeFranco Valle has directly acquired 5,199 shares and currently holds 5,199 shares.Buy
2020-10-09 17:35 ESTInsider TradeFranco Valle has directly disposed of 5,444 shares and currently holds 0 shares.Sell
2020-10-09 17:35 ESTInsider TradeFranco Valle has directly acquired 5,000 shares and currently holds 5,444 shares.Buy
2020-10-09 08:48 ESTAnalyst RatingThe Analyst Target Price has decreased from $63.66 to $62.81.Sell
2020-10-07 08:40 ESTAnalyst RatingThe Analyst Target Price has increased from $60.28 to $63.66.Neutral
2020-10-06 10:08 ESTNewsBridgeBio Pharma to acquire remaining 36.3% shares in Eidos TherapeuticsN/A
2020-10-06 08:42 ESTAnalyst RatingThe Analyst Target Price has increased from $59.38 to $60.28.Neutral
2020-10-02 20:19 ESTInsider TradeUma Sinha has directly disposed of 4,831 shares and currently holds 326,525 shares.Sell
2020-10-02 20:19 ESTInsider TradeUma Sinha has directly disposed of 100 shares and currently holds 331,356 shares.Sell
2020-10-02 20:19 ESTInsider TradeUma Sinha has directly disposed of 69 shares and currently holds 331,456 shares.Sell
2020-09-26 12:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-18 16:37 ESTInsider TradeJonathan C Fox has indirectly disposed of 5,767 shares.Sell
2020-09-17 04:46 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 19:05 ESTInsider TradeJonathan C Fox has indirectly disposed of 3,122 shares.Sell
2020-09-16 19:05 ESTInsider TradeJonathan C Fox has indirectly disposed of 1,000 shares.Sell
2020-09-16 19:05 ESTInsider TradeJonathan C Fox has indirectly disposed of 111 shares.Sell
2020-09-11 16:35 ESTInsider TradeCameron Turtle has directly disposed of 2,500 shares and currently holds 70,531 shares.Sell
2020-09-11 16:35 ESTInsider TradeCameron Turtle has directly acquired 2,500 shares and currently holds 73,031 shares.Buy
2020-09-09 04:44 ESTAnalyst RatingThe Analyst Target Price has increased from $56.43 to $59.38.Buy
2020-08-14 08:40 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 08:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-09 08:36 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 17:33 ESTNewsEidos Therapeutics EPS misses by $0.18N/A
2020-08-05 20:21 ESTInsider TradeCameron Turtle has directly disposed of 500 shares and currently holds 70,531 shares.Sell
2020-08-05 20:21 ESTInsider TradeCameron Turtle has directly disposed of 6,700 shares and currently holds 71,031 shares.Sell
2020-08-05 20:21 ESTInsider TradeCameron Turtle has directly disposed of 2,800 shares and currently holds 77,731 shares.Sell
2020-08-05 20:21 ESTInsider TradeCameron Turtle has directly acquired 5,000 shares and currently holds 80,531 shares.Buy

About Eidos Therapeutics, Inc (EIDX):

Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) or amyloidosis (ATTR). It is developing AG10, which is in phase 3 clinical trial, is an orally-administered small molecule designed to stabilize tetrameric TTR, thereby halting at its outset the series of molecular events that give rise to ATTR. The company was founded in 2013 and is headquartered in San Francisco, California. Eidos Therapeutics, Inc. is a subsidiary of BridgeBio Pharma, Inc.

EIDX Quotes by TradingView

See Advanced Chart

General

  • Name Eidos Therapeutics, Inc
  • Symbol EIDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 70
  • Fiscal Year EndDecember
  • IPO Date2018-06-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.eidostx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 38461.05
  • Price/Book (Most Recent Quarter) 40.64
  • Enterprise Value Revenue 38322.63
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.70
  • Operating Margin -77050%
  • Return on Assets -36%
  • Return on Equity -70%
  • Revenue 127000
  • Earnings Per Share -$1.27
  • Revenue Per Share $0
  • Gross Profit 24.19 million
  • Quarterly Earnings Growth -99.5%
View More

Highlights

  • Market Capitalization 4.75 billion
  • EBITDA -49006000
  • Analyst Target Price $53.63
  • Book Value Per Share $3.18
View More

Share Statistics

  • Shares Outstanding 38.87 million
  • Shares Float 13.31 million
  • % Held by Insiders 6526%
  • % Held by Institutions 31.08%
  • Shares Short 495615
  • Shares Short Prior Month 501510
  • Short Ratio 3.16
  • Short % of Float 4%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta -0.17
  • 52 Week High $132.54
  • 52 Week Low $38.24
  • 50 Day Moving Average 124.31
  • 200 Day Moving Average 77.38
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Eidos Therapeutics, Inc (EIDX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Eidos Therapeutics, Inc (EIDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-10-29$N/A-$0.79-$0.71-11.63%
2020-06-302020-08-06$N/A-$0.75-$0.56-35.06%
2020-03-312020-05-08$N/A-$0.60-$0.53-13.66%
2019-12-312020-02-26$N/A-$0.51-$0.48-6.41%
2019-09-302019-10-31$26.69 million$0.18-$0.27166.54%
2019-06-302019-08-01$N/A-$0.39-$0.37-4.75%
2019-03-312019-04-15$N/A-$0.27-$0.284.42%
2018-12-312019-02-27$N/A-$0.27-$0.25-9.12%
2018-09-302018-11-06$N/A-$0.29-$0.27-6.11%
2018-06-302018-08-07$N/A-$0.29-$0.23-26.93%

Eidos Therapeutics, Inc (EIDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A N/A 13.86 million 11.99 million
Income Before Tax N/A N/A N/A -18.98 million 6.93 million
Selling General Administrative N/A N/A N/A 5.47 million 4.15 million
Gross Profit N/A N/A N/A N/A 24.19 million
Ebit N/A N/A N/A -19.32 million 8.05 million
Operating Income N/A N/A N/A -19.32 million 8.05 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A 26.69 million
Cost of Revenue N/A N/A N/A N/A 2.5 million
Total Other Income Expense Net N/A N/A N/A 344000 -1.12 million
Net Income From Continuing Operations N/A N/A N/A -18.98 million 6.93 million
Net Income Applicable to Common Shares -30.18 million -28.85 million -22.82 million -18.98 million 6.93 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities 141000 -1.73 million N/A N/A 1.73 million
Total Cash Flow from Investing Activities -107000 -192000 N/A N/A -112000
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A N/A 23.55 million
Change to Operating Activities -1.57 million 5.45 million N/A N/A 617000
Change in Cash N/A N/A N/A N/A 34.42 million
Total Cash from Operating Activities -27.63 million -22.06 million N/A N/A 10.99 million
Depreciation N/A N/A N/A N/A 20000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A 114000
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 3.62 million 2.74 million N/A N/A 1.58 million
Capital Expenditures N/A N/A N/A N/A 112000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A N/A 32.39 million 14.94 million
Total Stockholder Equity N/A N/A N/A 171.43 million 163.95 million
Other Current Liabilities N/A N/A N/A N/A 145000
Total Assets N/A N/A N/A 203.82 million 178.89 million
Common Stock 39000 39000 39000 38000 38000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -184.95 million -154.78 million -125.93 million -103.11 million -84.13 million
Other Liabilities 3.8 million 1.16 million 1.17 million 1.26 million 129000
Other Assets 2.79 million 2.78 million 2.83 million 2.63 million 2.27 million
Cash N/A N/A N/A 191.16 million 165.82 million
Total Current Liabilities 13.83 million N/A N/A 10.43 million 10.08 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 5.01 million 5.1 million 5.18 million 5.27 million 5.32 million
Total Current Assets 153.55 million N/A N/A 195.92 million 171.31 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 122.86 million 149.31 million 174.85 million 171.43 million 163.95 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A 16.11 million N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 2.38 million N/A N/A 3.15 million 3.57 million

Eidos Therapeutics, Inc (EIDX) Chart:

Eidos Therapeutics, Inc (EIDX) News:

Below you will find a list of latest news for Eidos Therapeutics, Inc (EIDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Eidos Therapeutics, Inc (EIDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Eidos Therapeutics, Inc (EIDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320018110/0000899243-20-018110-index.htm
2020-06-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1731831/000000000020005537/0000000000-20-005537-index.htm
2020-07-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1731831/000000000020006097/0000000000-20-006097-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/0000899243-19-027574-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/0000899243-19-028027-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028028/0000899243-19-028028-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028029/0000899243-19-028029-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028274/0000899243-19-028274-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028617/0000899243-19-028617-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028831/0000899243-19-028831-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/0000899243-19-028932-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924319029765/0000899243-19-029765-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320000899/0000899243-20-000899-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320000901/0000899243-20-000901-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320001337/0000899243-20-001337-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320003247/0000899243-20-003247-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320005000/0000899243-20-005000-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320006941/0000899243-20-006941-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320006944/0000899243-20-006944-index.htm
2020-03-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320009640/0000899243-20-009640-index.htm
2020-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320011154/0000899243-20-011154-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320011341/0000899243-20-011341-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320012071/0000899243-20-012071-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320014409/0000899243-20-014409-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320014538/0000899243-20-014538-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320014539/0000899243-20-014539-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320014540/0000899243-20-014540-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320014544/0000899243-20-014544-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320014714/0000899243-20-014714-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320015410/0000899243-20-015410-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320015411/0000899243-20-015411-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320015413/0000899243-20-015413-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320015415/0000899243-20-015415-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320018110/0000899243-20-018110-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320018813/0000899243-20-018813-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320021565/0000899243-20-021565-index.htm
2020-08-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320021953/0000899243-20-021953-index.htm
2020-08-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320021954/0000899243-20-021954-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320021957/0000899243-20-021957-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320021958/0000899243-20-021958-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320024894/0000899243-20-024894-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320025364/0000899243-20-025364-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320025694/0000899243-20-025694-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320026974/0000899243-20-026974-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320027918/0000899243-20-027918-index.htm
2020-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320029938/0000899243-20-029938-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1731831/000089924320030216/0000899243-20-030216-index.htm
2020-10-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1731831/000110465920113116/0001104659-20-113116-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312519316217/0001193125-19-316217-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312520003080/0001193125-20-003080-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312520083086/0001193125-20-083086-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520119044/0001193125-20-119044-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1731831/000119312520119063/0001193125-20-119063-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312520157229/0001193125-20-157229-index.htm
2020-06-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520164620/0001193125-20-164620-index.htm
2020-07-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1731831/000119312520185181/0001193125-20-185181-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312520213106/0001193125-20-213106-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312520257175/0001193125-20-257175-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312520263868/0001193125-20-263868-index.htm
2020-10-05425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520263876/0001193125-20-263876-index.htm
2020-10-05425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520263882/0001193125-20-263882-index.htm
2020-10-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1731831/000119312520264026/0001193125-20-264026-index.htm
2020-10-06425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520264235/0001193125-20-264235-index.htm
2020-10-07425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520264972/0001193125-20-264972-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000119312520264980/0001193125-20-264980-index.htm
2020-10-07425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520264988/0001193125-20-264988-index.htm
2020-10-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1731831/000119312520270273/0001193125-20-270273-index.htm
2020-11-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1731831/000119312520283901/0001193125-20-283901-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1731831/000138713120001277/0001387131-20-001277-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000156459020006810/0001564590-20-006810-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1731831/000156459020006823/0001564590-20-006823-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000156459020023593/0001564590-20-023593-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1731831/000156459020023604/0001564590-20-023604-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000156459020037811/0001564590-20-037811-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1731831/000156459020037814/0001564590-20-037814-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1731831/000156459020048894/0001564590-20-048894-index.htm
2020-10-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1731831/000156459020048909/0001564590-20-048909-index.htm
2020-02-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1731831/999999999720000434/9999999997-20-000434-index.htm
2020-02-28SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1731831/999999999720001063/9999999997-20-001063-index.htm

Eidos Therapeutics, Inc (EIDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eidos Therapeutics, Inc (EIDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 6526%
Institutional Ownership: 3108%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Franco ValleSenior Vice President, FinanceSell1,000.0053.0653,060.000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320006944/0000899243-20-006944-index.htm
2020-03-26Franco ValleSenior Vice President, FinanceSell2,000.0048.8597,700.000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320009640/0000899243-20-009640-index.htm
2020-04-20Franco ValleSenior Vice President, FinanceSell2,000.0049.7999,580.000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320011154/0000899243-20-011154-index.htm
2020-10-07Franco ValleSenior Vice President, FinanceSell5,444.0075.08408,748.040.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320027918/0000899243-20-027918-index.htm
2020-10-08Franco ValleSenior Vice President, FinanceSell5,199.0074.85389,150.870.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320027918/0000899243-20-027918-index.htm
2020-03-02Franco ValleSenior Vice President, FinanceSell2,000.0051.96103,920.001,000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320006944/0000899243-20-006944-index.htm
2020-04-20Franco ValleSenior Vice President, FinanceBuy2,000.007.2414,480.002,000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320011154/0000899243-20-011154-index.htm
2020-03-26Franco ValleSenior Vice President, FinanceSell3,000.0047.87143,610.002,000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320009640/0000899243-20-009640-index.htm
2020-03-02Franco ValleSenior Vice President, FinanceBuy3,000.007.2421,720.003,000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320006944/0000899243-20-006944-index.htm
2020-10-29Uma SinhaChief Scientific OfficerSell3,700.0072.60268,625.92321,525.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320029938/0000899243-20-029938-index.htm
2020-10-29Uma SinhaChief Scientific OfficerSell1,300.0071.9093,473.12325,225.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320029938/0000899243-20-029938-index.htm
2020-10-01Uma SinhaChief Scientific OfficerSell4,831.0052.35252,923.14326,525.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320026974/0000899243-20-026974-index.htm
2020-05-31Jonathan C FoxOfficerBuy444.0041.5718,458.633,294.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320015413/0000899243-20-015413-index.htm
2019-12-18Uma SinhaChief Scientific OfficerSell1,702.0063.31107,760.60331,081.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319029765/0000899243-19-029765-index.htm
2020-09-30Uma SinhaChief Scientific OfficerSell100.0052.005,200.00331,356.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320026974/0000899243-20-026974-index.htm
2020-09-30Uma SinhaChief Scientific OfficerSell69.0052.083,593.52331,456.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320026974/0000899243-20-026974-index.htm
2020-05-31Uma SinhaChief Scientific OfficerBuy444.0041.5718,458.63331,525.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320015410/0000899243-20-015410-index.htm
2019-12-18Uma SinhaChief Scientific OfficerSell825.0062.4951,552.52332,783.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319029765/0000899243-19-029765-index.htm
2019-12-18Uma SinhaChief Scientific OfficerSell9,973.0061.61614,480.41333,608.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319029765/0000899243-19-029765-index.htm
2019-11-21Christine SiuCFO and SecretarySell200.0056.0011,200.0036,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/0000899243-19-028027-index.htm
2019-11-22Christine SiuCFO and SecretarySell601.0055.2933,232.2336,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/0000899243-19-028027-index.htm
2019-12-03Christine SiuCFO and SecretarySell4,000.0059.65238,582.8036,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2019-12-04Christine SiuCFO and SecretarySell1,200.0059.3971,271.8436,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2019-12-09Christine SiuCFO and SecretarySell901.0060.0554,101.0936,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/0000899243-19-028932-index.htm
2019-11-21Christine SiuCFO and SecretarySell24,800.0055.121,366,876.8036,670.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/0000899243-19-028027-index.htm
2019-11-22Christine SiuCFO and SecretarySell9,399.0054.71514,223.9937,071.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/0000899243-19-028027-index.htm
2019-12-09Christine SiuCFO and SecretarySell9,099.0059.62542,468.7337,371.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/0000899243-19-028932-index.htm
2019-12-04Christine SiuCFO and SecretarySell8,800.0058.60515,671.2037,670.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2020-09-17Jonathan C FoxOfficerSell5,767.0050.16289,258.88377,673.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320025694/0000899243-20-025694-index.htm
2020-09-16Jonathan C FoxOfficerSell3,122.0050.16156,609.51383,440.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320025364/0000899243-20-025364-index.htm
2020-09-15Jonathan C FoxOfficerSell1,000.0050.0650,064.00386,562.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320025364/0000899243-20-025364-index.htm
2020-09-14Jonathan C FoxOfficerSell111.0050.005,550.00387,562.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320025364/0000899243-20-025364-index.htm
2020-07-07Jonathan C FoxOfficerSell5,000.0050.00250,000.00387,673.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320018813/0000899243-20-018813-index.htm
2020-06-03Jonathan C FoxOfficerSell5,000.0050.00250,000.00391,585.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320015413/0000899243-20-015413-index.htm
2020-05-28Jonathan C FoxOfficerSell5,000.0050.00250,000.00398,625.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320014714/0000899243-20-014714-index.htm
2020-04-24Jonathan C FoxOfficerSell2,153.0050.00107,650.00403,625.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320011341/0000899243-20-011341-index.htm
2019-12-03Christine SiuCFO and SecretarySell5,400.0058.95318,332.1640,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2020-04-23Jonathan C FoxOfficerSell2,847.0050.00142,350.00405,778.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320011341/0000899243-20-011341-index.htm
2020-03-02Jonathan C FoxOfficerSell10,000.0051.57515,706.00408,625.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320006941/0000899243-20-006941-index.htm
2020-02-13Jonathan C FoxOfficerSell10,000.0054.00540,000.00418,625.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320005000/0000899243-20-005000-index.htm
2020-01-15Jonathan C FoxOfficerSell3,580.0055.00196,900.00430,257.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320001337/0000899243-20-001337-index.htm
2020-01-14Jonathan C FoxOfficerSell6,420.0055.01353,171.90433,837.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320001337/0000899243-20-001337-index.htm
2019-12-04Jonathan C FoxOfficerSell10,000.0058.90589,048.00440,527.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028617/0000899243-19-028617-index.htm
2020-05-31Franco ValleSenior Vice President, FinanceBuy444.0041.5718,458.63444.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320015411/0000899243-20-015411-index.htm
2019-11-25Jonathan C FoxOfficerSell10,000.0056.52565,218.00451,527.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028274/0000899243-19-028274-index.htm
2019-12-03Christine SiuCFO and SecretarySell600.0057.8234,692.7245,870.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2019-11-21Jonathan C FoxOfficerSell10,000.0055.11551,073.00461,527.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028028/0000899243-19-028028-index.htm
2019-11-22Christine SiuCFO and SecretaryBuy10,000.000.595,900.0046,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/0000899243-19-028027-index.htm
2019-12-03Christine SiuCFO and SecretaryBuy10,000.000.595,900.0046,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2019-12-04Christine SiuCFO and SecretaryBuy10,000.000.595,900.0046,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028602/0000899243-19-028602-index.htm
2019-12-09Christine SiuCFO and SecretaryBuy10,000.000.595,900.0046,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028932/0000899243-19-028932-index.htm
2019-11-18Jonathan C FoxOfficerSell10,000.0050.26502,574.00471,527.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/0000899243-19-027574-index.htm
2019-11-15Jonathan C FoxOfficerSell900.0046.4541,805.00481,527.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/0000899243-19-027574-index.htm
2019-11-15Jonathan C FoxOfficerSell2,100.0045.5195,567.22482,427.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/0000899243-19-027574-index.htm
2019-11-15Jonathan C FoxOfficerSell2,000.0044.8889,757.20484,527.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319027574/0000899243-19-027574-index.htm
2020-03-26Franco ValleSenior Vice President, FinanceBuy5,000.007.2436,200.005,000.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320009640/0000899243-20-009640-index.htm
2020-10-08Franco ValleSenior Vice President, FinanceBuy5,199.007.2437,640.765,199.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320027918/0000899243-20-027918-index.htm
2020-10-07Franco ValleSenior Vice President, FinanceBuy5,000.007.2436,200.005,444.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320027918/0000899243-20-027918-index.htm
2019-11-21Christine SiuCFO and SecretaryBuy25,000.000.5914,750.0061,470.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028027/0000899243-19-028027-index.htm
2020-11-02Cameron TurtleChief Business OfficerSell209.0072.1015,068.0865,531.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320030216/0000899243-20-030216-index.htm
2020-11-02Cameron TurtleChief Business OfficerSell3,146.0071.42224,676.9465,740.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320030216/0000899243-20-030216-index.htm
2020-11-02Cameron TurtleChief Business OfficerSell9,145.0070.44644,208.5568,886.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320030216/0000899243-20-030216-index.htm
2020-08-03Cameron TurtleChief Business OfficerSell500.0040.8920,446.3570,531.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320021565/0000899243-20-021565-index.htm
2020-09-10Cameron TurtleChief Business OfficerSell2,500.0047.00117,500.0070,531.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320024894/0000899243-20-024894-index.htm
2020-08-03Cameron TurtleChief Business OfficerSell6,700.0040.25269,671.6571,031.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320021565/0000899243-20-021565-index.htm
2020-09-10Cameron TurtleChief Business OfficerBuy2,500.0017.0042,500.0073,031.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320024894/0000899243-20-024894-index.htm
2020-05-01Cameron TurtleChief Business OfficerSell20.0043.26865.2075,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320012071/0000899243-20-012071-index.htm
2020-05-26Cameron TurtleChief Business OfficerSell2,500.0047.00117,500.0075,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320014409/0000899243-20-014409-index.htm
2020-05-01Cameron TurtleChief Business OfficerSell1,180.0042.5650,220.4575,175.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320012071/0000899243-20-012071-index.htm
2020-05-31Cameron TurtleChief Business OfficerBuy376.0041.5715,631.6475,531.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320015415/0000899243-20-015415-index.htm
2020-11-02Cameron TurtleChief Business OfficerBuy5,000.0013.2066,000.0075,531.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320030216/0000899243-20-030216-index.htm
2020-05-01Cameron TurtleChief Business OfficerSell1,050.0041.2343,286.5776,355.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320012071/0000899243-20-012071-index.htm
2020-05-01Cameron TurtleChief Business OfficerSell7,750.0040.52314,061.0077,405.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320012071/0000899243-20-012071-index.htm
2020-05-26Cameron TurtleChief Business OfficerBuy2,500.0017.0042,500.0077,655.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320014409/0000899243-20-014409-index.htm
2020-08-03Cameron TurtleChief Business OfficerSell2,800.0039.05109,331.8877,731.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320021565/0000899243-20-021565-index.htm
2020-11-02Cameron TurtleChief Business OfficerBuy2,500.0017.0042,500.0078,031.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320030216/0000899243-20-030216-index.htm
2020-02-03Cameron TurtleChief Business OfficerSell7,211.0053.89388,636.1280,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320003247/0000899243-20-003247-index.htm
2020-08-03Cameron TurtleChief Business OfficerBuy5,000.0013.2066,000.0080,531.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320021565/0000899243-20-021565-index.htm
2020-05-01Cameron TurtleChief Business OfficerBuy5,000.0013.2066,000.0085,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320012071/0000899243-20-012071-index.htm
2019-11-20Cameron TurtleChief Business OfficerSell2,532.0056.36142,696.9485,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028029/0000899243-19-028029-index.htm
2019-12-06Cameron TurtleChief Business OfficerSell8,900.0059.43528,921.6685,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028831/0000899243-19-028831-index.htm
2020-02-03Cameron TurtleChief Business OfficerSell5,289.0053.32282,003.6687,366.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320003247/0000899243-20-003247-index.htm
2019-11-20Cameron TurtleChief Business OfficerSell7,468.0055.54414,804.8387,687.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028029/0000899243-19-028029-index.htm
2020-02-03Cameron TurtleChief Business OfficerBuy5,000.0013.2066,000.0090,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320003247/0000899243-20-003247-index.htm
2020-02-03Cameron TurtleChief Business OfficerBuy2,500.0017.0042,500.0092,655.00https://www.sec.gov/Archives/edgar/data/1731831/000089924320003247/0000899243-20-003247-index.htm
2019-12-06Cameron TurtleChief Business OfficerSell700.0058.2840,793.9794,055.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028831/0000899243-19-028831-index.htm
2019-12-06Cameron TurtleChief Business OfficerSell400.0056.8422,736.0094,755.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028831/0000899243-19-028831-index.htm
2019-12-06Cameron TurtleChief Business OfficerBuy10,000.0013.20132,000.0095,155.00https://www.sec.gov/Archives/edgar/data/1731831/000089924319028831/0000899243-19-028831-index.htm